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Neuronal cells from cerebral hemispheres of 13-day-old rat embryos were grown in a serum-free culture 
medium for 48 h, 4 or 8 days. The neuronal precursor cells proliferate for 5 days. The addition of bovine 
brain basic fibroblast growth factor stimulates their proliferation as determined by measurement of [1zsIj- 
iod~eoxyu~dine inco~oration and by autoradio~aphic analysis after ~~thymidine incorporation. The 
proliferating responsive cells were characterized as neurons by immunostai~ng against neurofilament pro- 
teins. Five other growth factors tested were without effect on the proliferative activity of these neuronal 
cells. The present results how that bFGF is mitogenic n vitro for rat neuronal precursor cells of the central 
nervous ystem. 
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I. INTRODUCTION 
Little is known about factors which control the 
proliferation of neuronal precursor cells during 
brain development. We have previously shown 
that embryonic chick and rat brain neuroblasts in 
primary culture can proliferate [l-4]. A few other 
studies have also reported that neuroblasts from 
fetal rat brain show division in culture [5,6]. We 
then demonstrated that meningeal cells as well as 
meningeal and brain extracts stimulate the multi- 
plication of these neuroblasts [l-4]. In addition, 
brain extracts also enhance the development of 
glial cells [7,8]. Recently, we purified to homo- 
geneity from bovine brain two astroglial growth 
factors (AGFl, AGF2), which influence the pro- 
liferation and maturation of rat astroblasts in 
culture [9]. AGFl and AGF2 are identical to the 
acidic and basic fibroblast growth factor (FGF) 
[9], respectively. Basic FGF (bFGF) also stimulates 
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the proliferation of oligodendrocytes [IO]. We now 
report that bFGF enhances the proliferation of 
neuronal precursors from embryonic rat brain. 
Since iq rat brain this factor has been found to be 
localized essentially in neuronal cells [ 111, it may 
function as an autocrine growth factor for these 
cells during ontogenesis. 
2. MATERIALS AND METHODS 
Primary cultures of neuronal cells were 
established from cerebral hemispheres of 13-day- 
old rat embryos as in [4]. Meningeal membranes 
were removed prior to culture. Cells were plated in 
poly(L-lysine)-precoated Falcon petri dishes 
(5 f 10’ cells per 35 mm dish) in a serum- 
containing medium, consisting of Dulbecco’s 
modified Eagle’s Hl6 medium (DMEM, Flow 
Laboratories) containing 20% fetal calf serum 
(FCS, Flow Laboratories). After 2 h, cultures were 
switched to a serum-free chemically defined 
medium: DMEM plus 5 pg/ml insulin (Sigma), 
50 pg/ml transferrin (Sigma), 20 nM progesterone 
(Sigma), 100&M putrescine (Sigma) and 30 nM 
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sodium selenite (Merck). 4 h after culture initia- 
tion experimental cultures were treated for 24 h 
with bFGF, also called astroglial growth factor 2 
(AGF2) or with other growth factors (EGF, epider- 
ma1 growth factor from Sigma; PDGF, platelet- 
derived growth factor from Bioprocessing, UK; 
IGF-I, recombinant insulin-like growth factor I 
from Amgen, USA; IL-2, recombinant inter- 
leukin-2 from Transgene, Strasbourg; and throm- 
bin provided by the Centre de Transfusion 
Sanguine, Strasbourg). Pure bFGF was prepared 
from bovine brain in our laboratory according to 
our second purification procedure [9]. 
Neurons were identified by immunostaining 
against neurofilament (NF) proteins [4,12]. Rabbit 
anti-NF antiserum was kindly made available by 
Dr J.F. Leterrier, Centre de Neurochimie, 
Strasbourg. 
Cell proliferation was measured by 5-[1251]iodo- 
2’-deoxyuridine (‘251-dUrd) incorporation. At 
24 h, 0.25 &i 125 I-dUrd (5 Ci/mg, Amersham) 
was added to the culture medium (2 ml) and cells 
were harvested 24 h later. Cultures were rinsed 
four times with 0.9% NaCl. The cells were scraped 
off with a rubber policeman and sedimented at 
2000 x g for 10 min; the cell pellets were counted 
in an LKB 1260 gamma counter. 
For autoradiographic analysis of neuronal cell 
proliferation cultures were exposed for 24 h to 
2 ml nutrient medium containing 0.1 ,&i [6-3H]- 
thymidine ([3H]dThd, 20-30 Ci/mmol; CEA, 
France) per ml starting 4 h after culture initiation 
unless otherwise indicated. The radioactive 
medium was then removed, and cultures were 
rinsed 5 times with DMEM and supplied with fresh 
nutrient medium. After 8 days cultures were im- 
munostained with NF antiserum (1 : 100) [12], 
rinsed with distilled water, air-dried and submitted 
to autoradiography [13]. Ilford K5 photographic 
emulsion was used. The autoradiograms were ex- 
posed for 15 days in the dark at 4°C. 
3. RESULTS AND DISCUSSION 
The addition of bFGF to cultures derived from 
cerebral hemispheres of 13-day-old rat embryos 
stimulates the incorporation of 1251-dUrd into the 
cultured cells (table 1). Results are similar for 
cultures started at various cell concentrations rang- 
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Table 1 
Effect of various growth factors on neuronal cell 
proliferation 
Treatment Concentration ‘251-dUrd incorporation 
(olo of control) 
Control 1002 6 
bFGF 5 ng/ml 200 f 25 
EGF 10 ng/ml ill+ 11 
PDGF 2 U/ml 101 + 13 
IGF-I 60 ng/ml 104* 7 
IL-2 25 U/ml 113-t 6 
Thrombin 0.05 U/ml 107 k 15 
4 h after culture initiation cultures were treated with the 
various growth factors for 24 h. Values are means f SD 
from 4 independent experiments 
ing from 3 to 7.5 x lo5 cells per dish. The level of 
incorporation is 2-times higher in the treated 
cultures compared to controls. The dose-response 
curve for the stimulation by bFGF of the brain cell 
proliferation (fig. 1) shows that maximal responses 
(about 95-98% stimulation) are observed at con- 
centrations of 2-8 ng/ml culture medium. Among 
several purified growth factors only bFGF affects 
the proliferative activity of brain cells (table 1). 
A combination of tritiated thymidine ([3H]- 
dThd) autoradiography and immunoperoxidase 
technique for neurofilament (NF) proteins shows 
that neuronal cells are radioactive in control as 
well as in treated cultures (fig.2), indicating that 
neuronal precursor cells proliferate under our 
bFGF ng/ml 
Fig.1. Stimulation of cell proliferation by varying con- 
centrations of bFGF. 4 h after culture initiation cultures 
were treated for 24 h with the various amount of bFGF. 
Values are means + SD from triplicate cultures. 
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Fig.2. Combination of [3H]thymidine autoradiography 
and immunoperoxidase staining with rabbit anti-NF an- 
tibody of neuronal cell cultures treated with bFGF 
(5 ng/ml). Bar: 10gm. 
culture conditions. During the first days of culture, 
with and without bFGF, only a few cells exhibiting 
astroglial morphologies and immunostained 
against glial fibrillary acidic protein (GFAP) were 
seen. Moreover, only some of these cells were 
radiolabelled when [3H]dThd was added between 4 
and 24 h or 24 and 48 h. 
Between 3 and 6 days, under normal culture con- 
ditions, many round cells are associated into small 
clumps. Other cells are fusiform or of irregular 
shape bearing two or several processes and are 
dispersed between the aggregates (fig.3a). Most of 
these cells present a neuronal morphology and are 
positively immunostained for NF proteins (not 
shown). In the presence of bFGF the cellular 
clumps have increased in size compared to control 
cultures (fig.3b). Most cells and the dense fiber 
network contain NF proteins (not shown). The 
astroglial GFAP positive cells remain rare under 
this treatment, up to 4 days. At day 6 the number 
of GFAP positive cells represent less than 10% of 
the total population. 
We found an amount of 8.5, 27 and 16.5% 
radiolabelled NF+ neuronal cells to total NF+ cells 
for control cultures exposed to [3H]dThd from 4 to 
24 h, 24 to 48 h and 4 to 5 days, respectively. In 
the preparations treated with radioactive 
thymidine between 7 and 8 days radioactivity could 
no longer be detected in neurons. In the presence 
of bFGF and [3H]dThd from 4 to 24 h about 
4-times more radioactive neuronal cells were 
observed (table 2). When cells were treated with 
bFGF and with the radioactive precursor after 24 h 
too many cells were present in large aggregates and 
it was impossible to determine the number of 
radiolabelled neurons. 
The above results show that neuronal precursor 
cells from brain of 13-day-old rat embryos can 
proliferate for 5 days in our culture conditions and 
stop multiplying after 7 days. The highest pro- 
liferative activity was observed between 24 and 
48 h. Moreover, the present report is the first 
evidence that bFGF, which is mitogenic for glial 
cells and for a great variety of other cell types, is 
also a mitogen for neuronal precursor cells of the 
central nervous system. The selectivity of these 
cells for bFGF should be pointed out since they do 
not respond to five other well characterized growth 
factors which are active on the proliferation of 
glial cells. 
Since bFGF has been found to stimulate the 
development of astroglial [9] and oligodendroglial 
[lo] cells it can be considered possible that the 
trophic effect observed in the present study may be 
mediated via glial cells. However, in our culture 
system most of the cells were found to express NF 
protein and few cells show GFAP, at least up to 4 
days and even in the presence of bFGF. Moreover, 
determinations of 2 ‘,3 ‘-cyclic nucleotide 3 ‘-phos- 
phodiesterase activity performed on the cultures to 
check the eventual presence of oligodendroglial 
cells indicated that no activity was detectable 
before 2 weeks (not shown). Thus, the cultures ap- 
pear virtually devoid of glial cells, especially dur- 
ing the first 48 h after culture initiation when most 
of the experiments have been performed. There- 
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Fig.3. Phase-contrast micrographs of brain cells from 13-day-old rat embryos cultured in the absence (a) and presence 
(b) of bFGF (5 ng/ml). Cells were grown for 4 days. Bar: 50pm. 
fore, the effect of bFGF on neuroblast prolifera- 
tion is probably the result of a direct action. 
Recently, it has been shown by us [14] and 
others [15,16] that bFGF is able to support 
Table 2 
Stimulation of neuronal cell proliferation by bFGF 
% 3H-labelled NF+ neurons 
to total NF+ neurons 
Control 8.5 + 2.5 
bFGF (5 ng/ml) 31.5 * 3.5 
Approx. 1000 NF positive cells were counted in each case 
on autoradiograms. Results are means + SE of several 
counts from 2 independent experiments 
neuronal survival and to promote neurite out- 
growth. Since this factor has been found in rat 
brain to be localized essentially in neuronal cells 
[ll], neurons may both secrete and respond to 
bFGF. Thus, bFGF may function as an autocrine 
factor for these cells. 
Further studies will be required to investigate 
whether neuronal cells release bFGF to which they 
can respond and whether this factor plays an im- 
portant role in vivo on neuronal development dur- 
ing brain ontogenesis. 
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